Skip to main content
logo
Taho Pharmaceuticals Ltd. (TPE:6467)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
202.50
+15.50 (8.29%)
At close: Oct 22, 2026

Taho Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
10,6135,7302,274120120120
Market Cap Growth
26.31%151.98%1789.98%0%0%-80.46%
Enterprise Value
10,3215,3432,074393939
Last Close Price
202.50111.5044.352.302.302.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5357.20681.34-112.8718.9217.47
PB Ratio
30.7713.524.410.581.311.87
P/TBV Ratio
30.8313.554.410.581.311.87

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-635.26-36.816.175.70

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.030.11-0.08
Net Debt / Equity Ratio
-0.84-0.89-0.93-1.01-1.15-1.19
Net Debt / EBITDA Ratio
1.221.752.851.761.841.17
Net Debt / FCF Ratio
1.421.812.891.941.6722.63
Asset Turnover
0.010.02-0.010.05-
Quick Ratio
18.1915.0115.023.852.296.36
Current Ratio
18.3015.1215.093.912.396.42
Return on Equity (ROE)
-60.29%-45.62%-46.32%-80.79%-84.84%-
Return on Assets (ROA)
-36.52%-27.08%-25.20%-35.89%-33.66%-
Return on Capital Employed (ROCE)
-69.70%-51.20%-32.20%-54.20%-72.50%-77.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.26%-3.74%-7.36%-100.30%-55.10%-9.52%
FCF Yield
-1.93%-3.65%-7.29%-89.02%-52.87%-2.80%
Buyback Yield / Dilution
-5.52%-13.40%-17.18%-7.73%-3.77%33.75%